Beam Therapeutics (BEAM)
NASDAQ:BEAM
Want to see BEAM full AI Analyst Report?
Beam Therapeutics (BEAM) Ownership Overview
3.64% Insiders
21.24% Mutual Funds
4.39% Other Institutional Investors
27.84% ETFs
42.90% Public Companies and Individual Investors
The ownership structure of Beam Therapeutics (BEAM) stock is a mix of institutional, retail, and individual investors. Approximately 53.47% of the company’s stock is owned by Institutional Investors, 3.64% is owned by Insiders, and 42.90% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 29, 2025 | xxxxxxxxxxxxx | $12246 | |
Aug 01, 2025 | xxxxxxxxxxxxx | $991667 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $345590479 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $27527790 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,467,189 | Institution | 12.13% | 382,742,702 | |
| 10,063,111 | Institution | 9.79% | 308,937,508 | |
| 9,239,739 | Institution | 8.99% | 283,659,987 | |
| 8,544,767 | Institution | 8.32% | 262,324,347 | |
| 7,180,901 | Institution | 6.99% | 220,453,661 | |
| 5,027,219 | Institution | 4.89% | 154,335,623 | |
| 4,335,120 | Institution | 4.22% | 133,088,184 | |
| 3,929,854 | Institution | 3.82% | 120,646,518 | |
| 1,980,688 | Insider | 1.93% | 60,807,122 | |
| 1,150,205 | Insider | 1.12% | 35,311,294 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,180,901 | Institution | 6.99% | 220,453,661 | |
| 5,027,219 | Institution | 4.89% | 154,335,623 | |
| 1,101,691 | Institution | 1.07% | 33,821,914 | |
| 1,029,424 | Institution | 1.00% | 31,603,317 | |
| 1,008,408 | Institution | 0.98% | 30,958,126 | |
| 987,695 | Institution | 0.96% | 30,322,237 | |
| 868,487 | Institution | 0.85% | 26,662,551 | |
| 660,314 | Institution | 0.64% | 20,271,640 | |
| 569,078 | Institution | 0.55% | 17,470,695 | |
| 436,666 | Institution | 0.42% | 13,405,646 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,538,304 | Institution | 6.36% | 200,725,933 | |
| 3,621,468 | Institution | 3.52% | 109,839,124 | |
| 3,098,456 | Institution | 3.02% | 73,836,206 | |
| 2,247,029 | Institution | 2.19% | 68,983,790 | |
| 2,233,898 | Institution | 2.17% | 53,233,789 | |
| 2,212,153 | Institution | 2.15% | 67,913,097 | |
| 1,249,357 | Institution | 1.22% | 29,772,177 | |
| 1,101,420 | Institution | 1.07% | 26,246,839 | |
| 788,290 | Institution | 0.77% | 24,200,503 | |
| 688,089 | Institution | 0.67% | 21,124,332 |
FAQ
Who Owns Beam Therapeutics (BEAM)?
According to the latest TipRanks data, approximately 4.39% of the company's stock is held by institutional investors, 3.64% is held by insiders, and 42.90% is held by retail investors.
What percentage of Beam Therapeutics (BEAM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.39% of Beam Therapeutics (BEAM) stock is held by institutional investors.
What percentage of Beam Therapeutics (BEAM) stock is held by retail investors?
According to the latest TipRanks data, approximately 42.90% of Beam Therapeutics (BEAM) stock is held by retail investors.
Who owns the most shares of Beam Therapeutics (BEAM)?
Cathie Wood owns the most shares of Beam Therapeutics (BEAM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.